Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-12-21 00:00:00 ET · period of report 2022-12-20 · accession 0001883850-22-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-12-21 | 2022-12-20 | REGN | VAGELOS P ROY | Dir | I - Discretionary | $729.53 | -141 | 1,961 | -7% | -$102.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-20 | I | D | 30 | $728.86 | 2,072 | I By 401(k) Plan | — | — | (F1) Represents volume-weighted average price of sales of 30 shares of Company stock on December 20, 2022 at prices ranging from $728.81 to $728.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-12-20 | I | D | 111 | $729.71 | 1,961 | I By 401(k) Plan | — | — | (F2) Represents volume-weighted average price of sales of 111 shares of Company stock on December 20, 2022 at prices ranging from $729.44 to $729.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price. |